Related Experiment Video
Updated: Jun 12, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy
G M Felker1, R E Thompson, J M Hare
1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Insights
Identifying the specific cause of cardiomyopathy significantly impacts patient prognosis. Peripartum cardiomyopathy offers a better outlook, while infiltrative diseases, HIV, and doxorubicin therapy indicate a poorer prognosis for heart failure patients.
Area of Science:
- Cardiology
- Heart Failure Research
- Prognostic Biomarkers
Background:
- Previous heart failure prognosis studies focused on ischemic vs. non-ischemic cardiomyopathy.
- The prognostic significance of specific underlying causes of cardiomyopathy remains largely unknown.
Purpose of the Study:
- To investigate the prognostic value of specific etiologies in patients with cardiomyopathy.
- To compare survival rates across different causes of cardiomyopathy.
Main Methods:
- Evaluated outcomes of 1230 cardiomyopathy patients categorized by cause.
- Utilized Cox proportional-hazards analysis to assess survival associations.
- Included causes such as idiopathic, peripartum, myocarditis, ischemic heart disease, HIV, and doxorubicin therapy.
Main Results:
- Survival varied significantly based on cardiomyopathy cause over a 4.4-year follow-up.
- Peripartum cardiomyopathy showed better survival (HR 0.31) compared to idiopathic.
- Worse survival observed in infiltrative myocardial disease (HR 4.40), HIV infection (HR 5.86), doxorubicin therapy (HR 3.46), and ischemic heart disease (HR 1.52).
Conclusions:
- The specific cause of cardiomyopathy is a crucial prognostic factor for heart failure.
- Peripartum cardiomyopathy is associated with a favorable prognosis.
- Infiltrative myocardial diseases, HIV infection, and doxorubicin treatment confer a particularly poor prognosis.
Background:
Previous studies of the prognosis of patients with heart failure due to cardiomyopathy categorized patients according to whether they had ischemic or nonischemic disease. The prognostic value of identifying more specific underlying causes of cardiomyopathy is unknown.
Methods:
We evaluated the outcomes of 1230 patients with cardiomyopathy. The patients were grouped into the following categories according to underlying cause: idiopathic cardiomyopathy (616 patients), peripartum cardiomyopathy (51); and cardiomyopathy due to myocarditis (111), ischemic heart disease (91), infiltrative myocardial disease (59), hypertension (49), human immunodeficiency virus (HIV) infection (45), connective-tissue disease (39), substance abuse (37), therapy with doxorubicin (15), and other causes (117). Cox proportional-hazards analysis was used to assess the association between the underlying cause of cardiomyopathy and survival.
Results:
During a mean follow-up of 4.4 years, 417 patients died and 57 underwent cardiac transplantation. As compared with the patients with idiopathic cardiomyopathy, the patients with peripartum cardiomyopathy had better survival (adjusted hazard ratio for death, 0.31; 95 percent confidence interval, 0.09 to 0.98), and survival was significantly worse among the patients with cardiomyopathy due to infiltrative myocardial disease (adjusted hazard ratio, 4.40; 95 percent confidence interval, 3.04 to 6.39), HIV infection (adjusted hazard ratio, 5.86; 95 percent confidence interval, 3.92 to 8.77), therapy with doxorubicin (adjusted hazard ratio, 3.46; 95 percent confidence interval, 1.67 to 7.18), and ischemic heart disease (adjusted hazard ratio, 1.52; 95 percent confidence interval, 1.07 to 2.17).
Conclusions:
The underlying cause of heart failure has prognostic value in patients with unexplained cardiomyopathy. Patients with peripartum cardiomyopathy appear to have a better prognosis than those with other forms of cardiomyopathy. Patients with cardiomyopathy due to infiltrative myocardial diseases, HIV infection, or doxorubicin therapy have an especially poor prognosis.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

